Circulating CD8+CD28nullT Cytotoxic Cells in Polymyositis-A Possible Biomarker? Comment on the Article by Pandya Et Al

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.39942
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immortal Time Bias: Comment on the Article by Gwinnutt Et Al

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Missing Information About Disease Controls: Comment on the Article by Mangnus Et Al

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Response To: Immortal Time Bias: Comment on the Article by Gwinnutt Et Al

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Brief Comment on the Article About Human Anaplasmosis by Arraga-Alvarado Et Al.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2015English

Toward a Multidisciplinary Approach for Systemic Sclerosis: Comment on the Article by Baron Et Al

Arthritis Care and Research
Rheumatology
2017English

Could Γ/Δ T Cells Explain Adverse Effects of Zoledronic Acid? Comment on the Article by Reinhardt Et Al

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Rheumatoid Factor Reactivity of Expanded CD21-/low B Cells in Sjögren's Syndrome Patients: Comment on the Article by Glauzy Et Al

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Response To: ‘Mycophenolate Mofetil: A Step Forward in the Induction Treatment of ANCA-associated Vasculitis? Comment on the Article by Jones Et Al’ by Vandergheynst Et Al

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Reduction of CD83 Expression on B Cells and the Genetic Basis for Rheumatoid Arthritis: Comment on the Article by Thalayasingam Et Al

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy